09:36 AM EDT, 10/07/2024 (MT Newswires) -- T2 Biosystems ( TTOO ) said Monday it was starting a multi-year distribution agreement with Cardinal Health ( CAH ) , which will exclusively sell its direct-from-blood diagnostics equipment for the rapid detection of sepsis-causing pathogens.

Among the devices included under the new agreements are T2 Biosystems' ( TTOO ) US Food and Drug Administration-authorized T2Dx Instrument, T2Bacteria Panel and the T2Candida Panel. Financial terms and other details of the new contract were not disclosed.

Price: 111.65, Change: -0.34, Percent Change: -0.30